Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 3
2015 3
2018 1
2019 2
2020 1
2021 1
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean miao xiao yan (11 results)?
Integrative genomic and transcriptomic profiling reveals distinct molecular subsets in adult mixed phenotype acute leukemia.
Wang Q, Cai WZ, Wang QR, Zhu MQ, Yan LZ, Yu Y, Bao XB, Shen HJ, Yao H, Xie JD, Zhang TT, Zhang L, Xu XY, Shan Z, Liu H, Cen JN, Liu DD, Pan JL, Lu DR, Chen J, Xu Y, Zhang R, Wang Y, Xue SL, Miao M, Han Y, Tang XW, Qiu HY, Sun AN, Huang JY, Dai HP, Wu DP, Chen SN. Wang Q, et al. Among authors: miao m. Am J Hematol. 2023 Jan;98(1):66-78. doi: 10.1002/ajh.26758. Epub 2022 Oct 31. Am J Hematol. 2023. PMID: 36219502 Free article.
Danoprevir for the Treatment of Hepatitis C Virus Infection: Design, Development, and Place in Therapy.
Miao M, Jing X, De Clercq E, Li G. Miao M, et al. Drug Des Devel Ther. 2020 Jul 14;14:2759-2774. doi: 10.2147/DDDT.S254754. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32764876 Free PMC article. Review.
Despite its approval, the clinical use of danoprevir is currently limited to its combination with peginterferon alpha-2a and ribavirin, thereby driving its development towards interferon-free, ribavirin-free regimens with improved tolerability and adherence. In the foreseeable fu …
Despite its approval, the clinical use of danoprevir is currently limited to its combination with peginterferon alpha-2a and ribavirin, ther …
Exploration of efficacy and safety of combined therapy of basiliximab with ruxolitinib for grade 3-4 steroid-refractory acute graft-versus-host disease: a registered clinical trial (NCT05021276).
Zhou F, Pan T, Li X, Du F, Ma X, Zhang Y, Wu D, Han Y, Xue S, Miao M, Tao T, He X, Chen S. Zhou F, et al. Among authors: miao m. Bone Marrow Transplant. 2023 Aug;58(8):959-961. doi: 10.1038/s41409-023-02005-4. Epub 2023 May 30. Bone Marrow Transplant. 2023. PMID: 37253803 Clinical Trial. No abstract available.
GDC-0152 induces apoptosis through down-regulation of IAPs in human leukemia cells and inhibition of PI3K/Akt signaling pathway.
Hu R, Li J, Liu Z, Miao M, Yao K. Hu R, et al. Among authors: miao m. Tumour Biol. 2015 Feb;36(2):577-84. doi: 10.1007/s13277-014-2648-8. Epub 2014 Oct 2. Tumour Biol. 2015. PMID: 25273171
GDC-0152-induced cell proliferation inhibition in K562 cells was prevented by pan-caspase inhibitor. GDC-0152 also inhibited PI3K and Akt expression in K562 and HL60 cells. ...
GDC-0152-induced cell proliferation inhibition in K562 cells was prevented by pan-caspase inhibitor. GDC-0152 also inhibited PI3K and …